Levi & Korsinsky announces it has commenced an investigation of Cigna
Corp. (“Cigna” or the “Company”) (NYSE: CI) concerning possible
violations of federal securities laws by certain officers and directors.
The investigation concerns the Company’s January 22, 2016, disclosure
that it had received an enforcement letter from the Department of Health
& Human Services Centers for Medicare & Medicare Services (“CMS”),
citing noncompliant appeals and grievances procedures within the Company
dating back to at least 2013. In addition, CMS has imposed sanctions on
the Company by suspending the enrollment of and marketing to new
customers of all Cigna Medicare Advantage and Standalone Prescription
Drug Plan Contracts. To obtain additional information about the
investigation, go to:
http://zlk.9nl.com/cigna
or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com
or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, California, Connecticut and Washington D.C. The firm’s attorneys
have extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. Attorney advertising. Prior results
do not guarantee similar outcomes.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160330006249/en/
Copyright Business Wire 2016